Eds story the impact of modern medicine and clinical trials on my lung cancer meet ed cutler a lung cancer survivor and advocate from tampa fla as he shares the ups and downs of his treatment journey from standard care to two clinical trials to help others understand the positive impact innovative therapies can have. There are low survival rates for these patients pfizer has shown a strong commitment to developing precision drugs to improve the outcomes of mutation driven lung cancers especially in lung cancer the company should be applauded the approval of vizimpro marks the third fda approved rare lung cancer drug they market. In addition to working full time karen is a lung cancer patient advocate in honor of lung cancer awareness month we caught up with her to learn more about her advocacy efforts tell us a little bit about the work you do to build awareness about lung cancer through your writing and social media presence
How it works:
1. Register Trial Account.
2. Download The Books as you like ( Personal use )